Sink-traps are a major source for carbapenemase-producing Enterobacteriaceae transmission
Infection Control & Hospital Epidemiology · 2024
DOI: 10.1017/ice.2023.270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, 2024. Verfasst von Gili Regev-Yochay und 12 weiteren Autor:innen. Beteiligte Einrichtung: Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel. Hauptthemen laut MEDLINE: Carbapenem-Resistant Enterobacteriaceae, Enterobacteriaceae Infections. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objective
We studied the extent of carbapenemase-producing Enterobacteriaceae (CPE) sink contamination and transmission to patients in a nonoutbreak setting.
Methods
During 2017–2019, 592 patient-room sinks were sampled in 34 departments. Patient weekly rectal swab CPE surveillance was universally performed. Repeated sink sampling was conducted in 9 departments. Isolates from patients and sinks were characterized using pulsed-field gel electrophoresis (PFGE), and pairs of high resemblance were sequenced by Oxford Nanopore and Illumina. Hybrid assembly was used to fully assemble plasmids, which are shared between paired isolates.
Results
In total, 144 (24%) of 592 CPE-contaminated sinks were detected in 25 of 34 departments. Repeated sampling (n = 7,123) revealed that 52%–100% were contaminated at least once during the sampling period. Persistent contamination for >1 year by a dominant strain was common. During the study period, 318 patients acquired CPE. The most common species were Klebsiella pneumoniae , Escherichia coli , and Enterobacter spp. In 127 (40%) patients, a contaminated sink was the suspected source of CPE acquisition. For 20 cases with an identical sink-patient strain, temporal relation suggested sink-to-patient transmission. Hybrid assembly of specific sink-patient isolates revealed that shared plasmids were structurally identical, and SNP differences between shared pairs, along with signatures for potential recombination events, suggests recent sharing of the plasmids.
Conclusions
CPE-contaminated sinks are an important source of transmission to patients. Although traditionally person-to-person transmission has been considered the main route of CPE transmission, these data suggest a change in paradigm that may influence strategies of preventing CPE dissemination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel.
- Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
- Microbiology laboratory, Sheba Medical Center, Ramat-Gan, Israel.
- Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.
- Infectious Disease Unit, Sheba Medical Center, Ramat-Gan, Israel.
- Sheba Medical Center Management, Ramat-Gan, Israel.
ORCID-Profile: Ili Margalit
Zitieren
APA
Regev-Yochay, G., Margalit, I., Smollan, G., Rapaport, R., Tal, I., Hanage, W. P., Pinas Zade, N., Jaber, H., Taylor, B. P., Che, Y., Rahav, G., Zimlichman, E., & Keller, N. (2024). Sink-traps are a major source for carbapenemase-producing Enterobacteriaceae transmission. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2023.270
Vancouver
Regev-Yochay G, Margalit I, Smollan G, Rapaport R, Tal I, Hanage WP, et al. Sink-traps are a major source for carbapenemase-producing Enterobacteriaceae transmission. Infection Control & Hospital Epidemiology. 2024. doi:10.1017/ice.2023.270
BibTeX
@article{RegevYochay2024,
author = {Regev-Yochay, Gili and Margalit, Ili and Smollan, Gillian and Rapaport, Rotem and Tal, Ilana and Hanage, William P and Pinas Zade, Nani and Jaber, Hanaa and Taylor, Bradford P and Che, You and Rahav, Galia and Zimlichman, Eyal and Keller, Nati},
title = {Sink-traps are a major source for carbapenemase-producing Enterobacteriaceae transmission},
journal = {Infection Control & Hospital Epidemiology},
year = {2024},
doi = {10.1017/ice.2023.270}
}
EUVIMED